IRON METABOLISM IN PLASMODIUM

疟原虫中的铁代谢

• 批准号: 6374211
• 负责人: DAVID Joseph SULLIVAN
• 金额: $ 25.33万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-06-01 至 2004-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6374211
• 关键词: HeLa cells; Plasmodium falciparum; SDS polyacrylamide gel electrophoresis; antimalarial agents; cell line; chloroquine; divalent cations; drug resistance; drug screening /evaluation; erythrocyte membrane; erythrocytes; heme; immunoelectron microscopy; immunoprecipitation; intracellular transport; ion transport; iron metabolism; malaria; membrane transport proteins; microorganism culture; northern blottings; pharmacokinetics; polymerase chain reaction; quinoline; site directed mutagenesis; western blottings

An increase in antimalarial drug resistance is an important contributing component to the current escalating mortality due to Plasmodium falciparum malaria. Two major classes of currently used antimalarials, the quinolines like chloroquine and the endoperoxides like artmesinin, interfere with iron metabolism to kill the parasite. Iron chelators, while cytostatic for bacterial and mammalian cells, actually kill Plasmodium despite the availability of millimolar heme iron in the parasitized erythrocyte. This indicates that the amount of bioavailable iron is limited and crucial for parasite survival. Therefore, interference with iron metabolism is an important and promising chemotherapeutic target for Plasmodium. The long term objectives of this proposal are to improve targeted antimalarial chemotherapy by further definition of the vital sources of parasitic iron and by characterization of iron transport to essential compartments. Preliminary data implicate erythrocytic ferritin as a source of iron. Recent cloning of the P. falciparum homologue to the mammalian iron transporter Natural Resistance Associated Macrophage Protein (NRAMP) will enable characterization of parasite iron transport. The specific aims are to test erythrocytic iron as an iron source, to localize the compartments in which PfNRAMP resides, to assess the specificity of divalent metal cations transported by PfNRAMP, to evaluate the kinetics and inhibition of this proton/cation symporter and to analyze its level of expression amongst quinoline-sensitive and -resistant parasites. The techniques of Plasmodium culture in resealed erythrocytes, recombinant gene expression, immunolocalization, cell transfection, and site-directed mutagenesis will be used to achieve these aims. The significant impact of this research is to improve the understanding of Plasmodium iron metabolism that is perturbed by antimalarial drugs. To improve the present antimalarial armamentarium for the US military and travelers as well as endemic populations is an essential component of malarial control.

抗疟药物耐药性的增加是目前恶性疟原虫疟疾死亡率不断上升的一个重要因素。 目前使用的抗疟药主要有两类：喹啉类（如氯喹）和内过氧化物（如青蒿素），它们会干扰铁代谢以杀死寄生虫。 尽管寄生的红细胞中存在毫摩尔血红素铁，但铁螯合剂虽然对细菌和哺乳动物细胞具有细胞抑制作用，但实际上会杀死疟原虫。 这表明生物可利用的铁的量是有限的，并且对于寄生虫的生存至关重要。 因此，干扰铁代谢是疟原​​虫一个重要且有前景的化疗靶点。该提案的长期目标是通过进一步定义寄生铁的重要来源和铁转运至重要隔室的特征来改善靶向抗疟化疗。 初步数据表明红细胞铁蛋白是铁的来源。 最近克隆的恶性疟原虫与哺乳动物铁转运蛋白天然抗性相关巨噬细胞蛋白（NRAMP）的同源物将能够表征寄生虫铁转运。具体目的是测试红细胞铁作为铁源，定位 PfNRAMP 所在的区室，评估 PfNRAMP 转运的二价金属阳离子的特异性，评估该质子/阳离子同向转运体的动力学和抑制并分析其喹啉敏感和耐药寄生虫中的表达水平。 重新密封的红细胞中的疟原虫培养、重组基因表达、免疫定位、细胞转染和定点诱变技术将用于实现这些目标。 这项研究的重大影响是提高了对抗疟药物干扰的疟原虫铁代谢的认识。 改善美国军队、旅行者以及流行人群现有的抗疟疾装备是疟疾控制的重要组成部分。